Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis

Joint Bone Spine

Volumn 75, Issue 3, 2008, Pages 291-294

  Kisacik, Bunyamin ^a   Tufan, Abdurrahman ^a   Kalyoncu, Umut ^a   Karadag, Omer ^a   Akdogan, Ali ^a   Ozturk, Mehmet Akif ^a   Kiraz, Sedat ^a   Ertenli, Ihsan ^a   Calguneri, Meral ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute phase reactants; Ankylosing spondylitis; Mean platelet volume; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ACUTE PHASE RESPONSE; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; HEMOGLOBIN DETERMINATION; HUMAN; LEUKOCYTE COUNT; MALE; PROTEIN DETERMINATION; RHEUMATOID ARTHRITIS; SEX RATIO; THROMBOCYTE VOLUME;

ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PLATELET ACTIVATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 42749092272     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.06.016     Document Type: Article

References (26)

1. Wollheim F.A. Markers of disease in rheumatoid arthritis. Curr Opin Rheumatol 12 (2000 May) 200-204
2. Colglazier C.L., and Sutej P.G. Laboratory testing in the rheumatic diseases: a practical review. South Med J 98 (2005) 185-191
3. Nakamura R.M. Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis. J Clin Lab Anal 14 (2000) 305-313
4. Kavanaugh A. The role of the laboratory in the evaluation of rheumatic diseases. Clin Cornerstone 2 (1999) 11-25
5. Shmerling R.H. Diagnostic tests for rheumatic disease: clinical utility revisited. South Med J 98 (2005) 704-711 quiz 712-3, 728
6. Yildirim K., Karatay S., Melikoglu M.A., et al. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci 34 (2004) 423-426
7. Ruof J., and Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 26 (1999) 966-970
8. Aletaha D., Nell V.P., Stamm T., et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 7 (2005) R796-R806
9. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 24 (1997) 1477-1485
10. Sandhaus L.M., and Meyer P. How useful are CBC and reticulocyte reports to clinicians?. Am J Clin Pathol 118 (2002) 787-793
11. Bath P.M., and Butterworth R.J. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7 (1996) 157-161
12. Bath P., Algert C., Chapman N., et al., PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 35 (2004) 622-626
13. Endler G., Klimesch A., Sunder-Plassmann H., et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 117 (2002) 399-404
14. Kapsoritakis A.N., Koukourakis M.I., Sfiridaki A., et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 96 (2001) 776-781
15. Milovanovic M., Nilsson E., and Jaremo P. Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 343 (2004) 237-240
16. Baynes R.D., Lamparelli R.D., Bezwoda W.R., et al. Platelet parameters. Part II. Platelet volume-number relationships in various normal and disease states. S Afr Med J 73 (1988) 39-43
17. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
18. van der Linden S., Valkenburg H.A., and Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27 (1984) 361-368
19. Prevoo M.L., van't Hof M.A., Kuper H.H., et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38 (1995) 44-48
20. Garrett S., Jenkinson T., Kennedy L.G., et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21 (1994) 2286-2291
21. Bowman S.J. Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol 31 (2002) 251-259
22. Bertero M.T., and Caligaris-Cappio F. Anemia of chronic disorders in systemic autoimmune diseases. Haematologica 82 (1997) 375-381
23. Ertenli I., Kiraz S., Ozturk M.A., et al. Pathologic thrombopoiesis of rheumatoid arthritis. Rheumatol Int 23 (2003) 49-60
24. Nishimoto N. Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol 18 (2006) 277-281
25. Kaser A., Brandacher G., Steurer W., et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98 (2001) 2720-2725
26. Butkiewicz A.M., Kemona H., Dymicka-Piekarska V., et al. Platelet count, mean platelet volume and thrombocytopoietic indices in healthy women and men. Thromb Res 118 (2006) 199-204